Hu Meng is a Senior Scientist at insitro since October 2025, specializing in the design, development, and qualification of LC-MS/MS methods for quantifying oligonucleotides, biologics, and small molecules in biological matrices to support pharmacokinetic, pharmacodynamic, and toxicokinetic studies. Prior experience includes a role as Senior Scientist I at ReCode Therapeutics from April 2022 to August 2025, where analytical methods were developed to assess critical quality attributes of mRNA drug substances and LNP-mRNA drug products, with expertise in various analytical techniques such as LC-MS and capillary gel electrophoresis. As Scientist II at the University of Pennsylvania from February 2016 to May 2022, research focused on proteomics in circadian biology, utilizing LC-MS and developing untargeted proteomics methods. Educational qualifications include a Ph.D. in Physical Chemistry and a B.Sc. in Chemistry, both from Peking University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices